Marilyn Stebbins, clinical professor in the UCSF School of Pharmacy, explains what has gone wrong with Part D so far, and how seniors can protect themselves and their drug benefits.
A UCSF expert says he hopes the recent US Supreme Court ruling will shine a light on the generally poor quality of care available to many people facing the end of life.